Abdominal Drainage in the Postoperative Period of Liver Transplantation (DRALIT)
NCT05688137 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 365
Last updated 2023-01-18
Summary
Classically, in the postoperative period of liver transplantation (LT), abdominal drainage has been used as a way to make the early diagnosis of hemorrhages, bile leaks and other postsurgical complications, as well as an evacuation route for ascites. The use of it routinely is currently under discussion due to the morbidities associated with its use.
Conditions
- Liver Transplant; Complications
- Drainage
Interventions
- PROCEDURE
-
Abdominal drainage
The patients with intervention will take an abdominal drainage.
Sponsors & Collaborators
-
Hospital Universitario Virgen de la Arrixaca
lead OTHER
Principal Investigators
-
Álvaro Cerezuela Fernández de Palencia · Hospital Universitario Virgen de la Arrixaca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-15
- Primary Completion
- 2024-07-01
- Completion
- 2024-07-01
More Related Trials
-
Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver Transplant
NCT01328132 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Splenic Artery Ligation in LDLT for Patients With Portal Hypertension
NCT04988100 ·Status: UNKNOWN ·Phase: NA
-
Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
NCT02401490 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
NCT00511394 ·Status: SUSPENDED ·Phase: NA
-
Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis.
NCT05883891 ·Status: COMPLETED
-
Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients
NCT05195125 ·Status: UNKNOWN ·Phase: PHASE1
-
Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
NCT06812390 ·Status: RECRUITING ·Phase: PHASE2
-
Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.
NCT02467348 ·Status: COMPLETED ·Phase: NA
-
Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT
NCT03448679 ·Status: COMPLETED
-
Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics
NCT02818673 ·Status: UNKNOWN ·Phase: PHASE3
-
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver Transplantation
NCT04472312 ·Status: COMPLETED
-
Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis
NCT03144713 ·Status: COMPLETED ·Phase: NA
-
Perioperative Use of Amino Acids in Recipients of Orthotopic Liver Transplantation as a Renal Protective Factor
NCT07004387 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection
NCT02329821 ·Status: COMPLETED
-
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study
NCT01091233 ·Status: WITHDRAWN
-
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
NCT05895136 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis
NCT01932151 ·Status: COMPLETED ·Phase: NA
-
Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
NCT04397289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
NCT00742339 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status
NCT03214796 ·Status: COMPLETED
-
Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.
NCT02867293 ·Status: COMPLETED ·Phase: NA
-
RCA for CRRT in Liver Failure and High Risk Bleeding Patients
NCT03791190 ·Status: UNKNOWN ·Phase: NA
-
Splenic Artery Ligation and Portocaval Shunt in Small-for-size Syndrome
NCT05459883 ·Status: COMPLETED
-
Midodrine and Albumin in Patients With Refractory Ascites
NCT04621617 ·Status: UNKNOWN ·Phase: PHASE3
-
Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation
NCT03789383 ·Status: RECRUITING